Table 1.
Patient demographics
| Variables | Entire cohort (n=17) |
|---|---|
| Age | 73.0 ± 9.28 |
| Female | 6 (35.5) |
| Hypertension | 14 (82.4) |
| Hyperlipidemia | 13 (76.5) |
| Diabetes | 4 (23.5) |
| Chronic kidney disease | 9 (52.9) |
| Dialysis | 2 (11.8) |
| COPD | 2 (11.8) |
| Porcelain aorta | 5 (29.4) |
| Left ventricular ejection fraction Permanent pacemaker | 44.7 ± 15.9 6 (35.3) |
| BMI | 28.0 ± 25.8 |
| BSA | 1.95 ± 0.19 |
| NYHA Functional Classification at original TAVR | |
| 1 | 0 |
| 2 | 3 (17.6) |
| 3 | 11 (64.7) |
| 4 | 3 (17.6) |
| Etiology | |
| Degenerative aortic stenosis | 13 (76.4) |
| Rheumatic | 1 (5.9) |
| Aortic root aneurysm | 2 (11.8) |
| Radiation-induced | 1 (5.9) |
| Bicuspid valve | 3 (17.6) |
| Previous cardiac surgery | 8 (47.1) |
| Redo sternotomy | |
| Isolated AVR | 2 (11.8) |
| Aortic root + ascending | 3 (17.6) |
| AVR + CABG | 1 (5.9) |
| Direct aortic TAVR | 1 (5.9) |
| Re-redo sternotomy | |
| AVR followed by AVR + ascending | 1 (5.9) |
| Valve-in-valve TAVR | 7 (41.2) |
| Recipient surgical valve | |
| Freestyle | 4 (57.1) |
| Perimount | 1 (14.3) |
| Mosaic | 1 (14.3) |
| Homograft | 1 (14.3) |
| STS-PROM at original TAVR | 3.5 (2.6-4.9) |
| With incremental factors | 8.7 (5.2-13.4) |
| Risk Classification at original TAVR | |
| Extreme risk | 3 (17.7) |
| High risk | 7 (41.2) |
| Moderate risk | 7 (41.2) |
COPD, chronic obstructive pulmonary disease; BMI, body mass index; BSA, body surface area; STS-PROM, Society of Thoracic Surgeons Predicted Risk of Mortality; CABG, coronary artery bypass grafting; TAVR, transcatheter aortic valve replacement; AVR, aortic valve replacement; NYHA, New York Heart Association